Top Markets
Coin of the day
Anbio Biotechnology Class A Ordinary Shares Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology Class A Ordinary Shares

NNNN
Rang in Aktien #16102
Anbio Biotechnology, established in 2021 and based in Frankfurt am Main,... Anbio Biotechnology, established in 2021 and based in Frankfurt am Main, Germany, operates as a global supplier of in vitro diagnostics (IVD) products. The company's international footprint covers regions such as the European Union, Asia Pacific, North America, South America, and Africa. Their product range features various diagnostic solutions, including rapid antigen tests for SARS-CoV-2 (both individual and combined with influenza A/B). Anbio also develops and manufactures products leveraging advanced technologies like lateral flow immunoassay, fluorescence immunoassay, loop-mediated isothermal amplification (LAMP), chemiluminescence immunoassay (CLIA), and reverse-transcription polymerase chain reaction (RT-PCR). These offerings cater to a wide array of markets, including over-the-counter sales, point-of-care testing, and traditional laboratory settings.
Aktienkurs
$7.15
Marktkapitalisierung
$313.60M
Veränderung (1 Tag)
-2.12%
Veränderung (1 Jahr)
-84.14%
Land
DE
Handel Anbio Biotechnology Class A Ordinary Shares (NNNN)

Kategorie

Dividendenrendite-Verlauf für Anbio Biotechnology Class A Ordinary Shares (NNNN)
Dividendenrendite (TTM) von Anbio Biotechnology Class A Ordinary Shares (Aktienkürzel: NNNN) zum 2026: 0
Durchschnittliche Dividendenrendite der letzten 5 Jahre: 0.00%
Dividendenrendite-Verlauf für Anbio Biotechnology Class A Ordinary Shares (NNNN) von 2026 bis 2026
Dividendenrendite am Ende jedes Jahres (TTM)
Jahr Dividendenrendite ändert
Nicht genügend Daten für die angegebenen Daten.
Dividendenrenditen (TTM) für ähnliche Unternehmen oder Wettbewerber